WallStreetZenWallStreetZen

NASDAQ: CME
Cme Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CME past earnings growth

How has CME's earnings growth performed historically?
Company
14.31%
Industry
0.01%
Market
40.67%
CME's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CME's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CME's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CME past revenue growth

How has CME's revenue growth performed historically?
Company
7.83%
Industry
4.48%
Market
14.14%
CME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CME's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CME earnings and revenue history

Current Revenue
$5.3B
Current Earnings
$3.0B
Current Profit Margin
56.3%
CME's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CME Return on Equity

Current Company
10.9%
Current Industry
5.7%
Current Market
-9.5%
CME's Return on Equity (10.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CME announces earnings.

CME Return on Assets

Current Company
2%
Current Industry
5.9%
CME is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CME Return on Capital Employed

Current Company
10.88%
Current Industry
12%
CME has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CME vs Financial Datum & Stock Exchange Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CME$5.35B$4.46B$3.01B+6.12%-8.83%
MCO$5.73B$2.43B$1.51B+4.71%+7.76%
ICE$9.61B$4.71B$2.42B+9.74%-0.77%
MSCI$2.42B$1.50B$960.18M+11.41%+20.77%
COIN$2.78B-$499.42M-$735.57M-31.46%N/A
View Top Financial Datum & Stock Exchange Stocks

CME earnings dates

Next earnings date
Feb 6, 2024

Cme Group Earnings & Revenue FAQ

What were CME's earnings last quarter?

On Invalid Date, Cme Group (NASDAQ: CME) reported Q3 2023 earnings per share (EPS) of $2.06, up 10.16% year over year. Total Cme Group earnings for the quarter were $740.80 million. In the same quarter last year, Cme Group's earnings per share (EPS) was $1.87.

If you're new to stock investing, here's how to buy Cme Group stock.

What was CME's earnings growth in the past year?

As of Q4 2023, Cme Group's earnings has grown 14.31% year over year. This is 14.29 percentage points higher than the US Financial Data & Stock Exchanges industry earnings growth rate of 0.01%. Cme Group's earnings in the past year totalled $3.01 billion.

What is CME's earnings date?

Cme Group's earnings date is Invalid Date. Add CME to your watchlist to be reminded of CME's next earnings announcement.

What was CME's revenue last quarter?

On Invalid Date, Cme Group (NASDAQ: CME) reported Q3 2023 revenue of $1.34 billion up 8.96% year over year. In the same quarter last year, Cme Group's revenue was $1.23 billion.

What was CME's revenue growth in the past year?

As of Q4 2023, Cme Group's revenue has grown 7.83% year over year. This is 3.36 percentage points higher than the US Financial Data & Stock Exchanges industry revenue growth rate of 4.48%. Cme Group's revenue in the past year totalled $5.35 billion.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.